title: On "Composition, Quality Control, and Labeling of Plasma-Derived Products for the Treatment of von Willebrand disease" (Semin Thromb Hemost 2006;32: 529-536).
authors.forename: Tor-Einar
authors.initials: TE
authors.lastname: Svae
authors.forename: Lothar
authors.initials: L
authors.lastname: Biesert
authors.forename: Andrea
authors.initials: A
authors.lastname: Neisser-Svae
authors.forename: Christoph
authors.initials: C
authors.lastname: Kannicht
authors.forename: Jürgen
authors.initials: J
authors.lastname: Römisch
mesh_terms: D016913:Blood Component Transfusion / Q000009:adverse effects / Q000592:standards*; D006801:Humans; D011786:Quality Control; D038301:Virus Inactivation; D014842:von Willebrand Diseases / Q000150:complications / Q000628:therapy*